Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

AGC Looks to Advance Into Gene and Cell Therapy Business With Tender Offer for MolMed

Filed Under: Industry Tagged With: , , , , ,

AGC Inc. (TYO:5201) recently announced that it intends to launch a tender offer for the acquisition of MolMed S.p.A., an…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Ajinomoto Makes Moves With Advanced Products in Biopharma SectorAjinomoto Makes Moves With Advanced Products in…
Sumitomo Chemical Set to Manufacture RNA for CRISPR Gene EditingSumitomo Chemical Set to Manufacture RNA for CRISPR…
Fujifilm Creates Genome-Edited Epidermis Model, Replicates Changes Caused by AgeFujifilm Creates Genome-Edited Epidermis Model,…
JSR Will Buy Swiss Selexis to Expand Biopharma BusinessJSR Will Buy Swiss Selexis to Expand Biopharma Business
Hitachi Chemical Plans European Medical Supplies BaseHitachi Chemical Plans European Medical Supplies Base
Astellas to Acquire US Gene Therapy Venture AudentesAstellas to Acquire US Gene Therapy Venture Audentes
Send this to a friend